TY - JOUR
T1 - Regulation of autophagy by stress-responsive transcription factors
AU - Pietrocola, Federico
AU - Izzo, Valentina
AU - Niso-Santano, Mireia
AU - Vacchelli, Erika
AU - Galluzzi, Lorenzo
AU - Maiuri, Maria Chiara
AU - Kroemer, Guido
N1 - Funding Information:
Authors are supported by the European Commission (ArtForce) ; Agence National de la Recherche (ANR) ; Ligue Nationale contre le Cancer; Fondation pour la Recherche Médicale (FRM) ; Institut National du Cancer (INCa) ; Association pour la Recherche sur le Cancer (ARC) ; LabEx Immuno-Oncologie; Fondation de France ; Fondation Bettencourt-Schueller ; AXA Chair for Longevity Research ; Cancéropôle Ile-de-France ; Paris Alliance of Cancer Research Institutes (PACRI) ; and Cancer Research for Personalized Medicine (CARPEM).
PY - 2013/10/1
Y1 - 2013/10/1
N2 - Autophagy is an evolutionarily conserved process that promotes the lysosomal degradation of intracellular components including organelles and portions of the cytoplasm. Besides operating as a quality control mechanism in steady-state conditions, autophagy is upregulated in response to a variety of homeostatic perturbations. In this setting, autophagy mediates prominent cytoprotective effects as it sustains energetic homeostasis and contributes to the removal of cytotoxic stimuli, thus orchestrating a cell-wide, multipronged adaptive response to stress. In line with the critical role of autophagy in health and disease, defects in the autophagic machinery as well as in autophagy-regulatory signaling pathways have been associated with multiple human pathologies, including neurodegenerative disorders, autoimmune conditions and cancer. Accumulating evidence indicates that the autophagic response to stress may proceed in two phases. Thus, a rapid increase in the autophagic flux, which occurs within minutes or hours of exposure to stressful conditions and is entirely mediated by post-translational protein modifications, is generally followed by a delayed and protracted autophagic response that relies on the activation of specific transcriptional programs. Stress-responsive transcription factors including p53, NF-κB and STAT3 have recently been shown to play a major role in the regulation of both these phases of the autophagic response. Here, we will discuss the molecular mechanisms whereby autophagy is orchestrated by stress-responsive transcription factors.
AB - Autophagy is an evolutionarily conserved process that promotes the lysosomal degradation of intracellular components including organelles and portions of the cytoplasm. Besides operating as a quality control mechanism in steady-state conditions, autophagy is upregulated in response to a variety of homeostatic perturbations. In this setting, autophagy mediates prominent cytoprotective effects as it sustains energetic homeostasis and contributes to the removal of cytotoxic stimuli, thus orchestrating a cell-wide, multipronged adaptive response to stress. In line with the critical role of autophagy in health and disease, defects in the autophagic machinery as well as in autophagy-regulatory signaling pathways have been associated with multiple human pathologies, including neurodegenerative disorders, autoimmune conditions and cancer. Accumulating evidence indicates that the autophagic response to stress may proceed in two phases. Thus, a rapid increase in the autophagic flux, which occurs within minutes or hours of exposure to stressful conditions and is entirely mediated by post-translational protein modifications, is generally followed by a delayed and protracted autophagic response that relies on the activation of specific transcriptional programs. Stress-responsive transcription factors including p53, NF-κB and STAT3 have recently been shown to play a major role in the regulation of both these phases of the autophagic response. Here, we will discuss the molecular mechanisms whereby autophagy is orchestrated by stress-responsive transcription factors.
KW - AMPK
KW - Beclin 1
KW - Cancer
KW - MTOR
KW - Mitophagy
KW - PKR
UR - http://www.scopus.com/inward/record.url?scp=84884820652&partnerID=8YFLogxK
U2 - 10.1016/j.semcancer.2013.05.008
DO - 10.1016/j.semcancer.2013.05.008
M3 - Review article
C2 - 23726895
AN - SCOPUS:84884820652
SN - 1044-579X
VL - 23
SP - 310
EP - 322
JO - Seminars in Cancer Biology
JF - Seminars in Cancer Biology
IS - 5
ER -